To further validate the stable increase of FAP+ CAFs in the tumor microenvironment, we integrated a single-cell validation cohort comprising 79 samples 19, 50, and which demonstrated a gradual increase in the proportion of FAP+ CAFs from AL, HCC, to ICC (Figure 1I). The gene discussed is FAP; the disease is neoplasm.